| Zhang, Helong |
TORCHLIGHT, NCT04085276: Toripalimab in Combination With Nab-Paclitaxel For Patients With Metastatic or Recurrent Triple-Negative Breast Cancer (TNBC) With or Without Systemic Treatment |
|
|
| Active, not recruiting | 3 | 531 | RoW | JS001, Nab-Paclitaxel, Placebo | Shanghai Junshi Bioscience Co., Ltd. | Triple-Negative Breast Cancer | 12/24 | 12/25 | | |
NCT04990063: Adoptive TKC Transfer Combined With Chemotherapy for Advanced Non-small Cell Lung Cancer (NSCLC) |
|
|
| Recruiting | 1 | 20 | RoW | Chemotherapy, Adoptive TKC transfer therapy | suhaichuan, Shanghai Biomed-union Biotechnology Co., Ltd. | Advanced Non-small Cell Lung Cancer, Chemotherapy | 08/22 | 11/23 | | |
| Min, Jie |
NCT06467786: Study on the Therapeutic Effect of Irinotecan Liposomes in Small Cell Lung Cancer |
|
|
| Recruiting | 4 | 24 | RoW | Irinotecan hydrochloride liposome injection | Tang-Du Hospital | Small Cell Lung Cancer | 09/25 | 09/28 | | |
NCT06475209: Adebrelimab + Apatinib in SCLC Maintenance Therapy |
|
|
| Recruiting | 2 | 60 | RoW | Adebrelimab combined with Apatinib | Tang-Du Hospital, Jiangsu Hengrui Pharmaceutical Co., Ltd. | SCLC | 12/25 | 12/26 | | |
NCT06352502: An Observational Study of Furmonertinib for EGFR Mutation-positive NSCLC Patients With Brain Metastasis |
|
|
| Recruiting | N/A | 30 | RoW | Furmonertinib, AST2818 | Tang-Du Hospital | EGF-R Positive Non-Small Cell Lung Cancer, CNS Metastases | 09/24 | 09/24 | | |
